Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

CAPS Rating: 1 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

Recs

0
Player Avatar monoclonal (< 20) Submitted: 1/25/2010 6:11:13 PM : Outperform Start Price: $26.10 REGN Score: +385.58

Very strong pipeline, with some exciting results due out at the end of this year.

Featured Broker Partners


Advertisement